Skip to search formSkip to main contentSkip to account menu

Vasoflux

National Institutes of Health

Related topics

Related topics

2 relations
analogs & derivatives

Broader (1)

heparin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial…
BACKGROUND Vasoflux is a low-molecular-weight heparin derivative that inhibits factor IXa activation of factor X and catalyzes… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)